Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma

ConclusionsPatients ≤60 years may undergo LT for HCC with favourable outcomes independently of their tumour burden. Additional assessment of tumour biology, e.g. using the DNA index, especially in this subgroup of patients can support the selection of LT candidates who may derive the most long‐term survival benefit, even if Milan criteria are not fulfilled.

Source: HPB: official journal of the International Hepato Pancreat Biliary Association - September 29, 2014 Category: Gastroenterology Authors: Andreas Andreou, Safak Gül, Andreas Pascher, Wenzel Schöning, Hussein Al‐Abadi, Marcus Bahra, Fritz Klein, Timm Denecke, Benjamin Strücker, Gero Puhl, Johann Pratschke, Daniel Seehofer Tags: Original Article Source Type: research